|
|
|
|
|
|
Free Newsletters
Archive
My eNewsletters
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Login
Become a Member
Discussion Forums
FAQ
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
ImmunoGen, Inc. (IMGN) Signs Lease for Waltham Building
8/24/2007
Boston Business Journal -- ImmunoGen Inc. signed a lease to move its headquarters to 88,930 square feet of office and laboratory space owned by Intercontinental Real Estate Corp.
The Boston Business Journal reported in June that the biopharmaceutical company was negotiating a lease to move out of its current headquarters in East Cambridge for 830 Winter St. in Waltham, Mass. ImmunoGen, which develops novel targeted anticancer therapeutics, will occupy office and laboratory space on each of three floors at 182,106-square-foot building.
"ImmunoGen is excited to have the opportunity to bring all of our research operations into a single facility along with our corporate offices," said Daniel M. Junius, chief financial officer of ImmunoGen Inc., in a statement. "We think 830 Winter St. is ideally suited to our needs and will provide us high-quality lab and office space for many years."
ImmunoGen (Nasdaq:IMGN - News) was represented in the lease by T3 Advisors LLC and the landlord, Intercontinental Real Estate, was represented by Richards Barry Joyce & Partners LLC.
|
|
|
|
|
|
|
|
|
|
|
|